Treatment of Guillain-Barré syndrome with high-dose gammaglobulin

Autor(es): Kleyweg R P,van der Meché F G,Meulstee J


Resumo: Intravenous gammaglobulin (IVGG) can improve the clinical course of several immune-mediated diseases. We report the first results of such treatment in eight patients with severe Guillain-Barré syndrome (GBS). We observed that IVGG was beneficial in at least some of the patients with severe GBS. These results should be confirmed in a randomized trial.


Imprenta: Neurology, v. 38, n. 10, p. 1639-1641, 1988


Identificador do objeto digital: 10.1212/WNL.38.10.1639


Descritores: Guillain-Barre Syndrome - Proteins


Data de publicação: 1988